Bond.az White LogoBond.az Black Logo

#cogent-biosciences

Latest news and interesting information about cogent-biosciences.

Today / 12:01
|
475

Cogent Stock Price Target Raised to $55

Cogent Biosciences PEAK trial: combination therapy shows 45.6% response rate, 16.5 months PFS, FDA accepts NDA. H.C. Wainwright raises price target to $55.

0
...